Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Clinical outcomes of implantation of posterior chamber phakic intraocular lens with CentraFLOW technology (Hole ICL) for moderate to high myopia

Poster Details

First Author: J.Zhou CHINA

Co Author(s):                        

Abstract Details


Aim To assess the safety, efficacy, predictability and stability of implantation of Visian ICL with CentraFLOW technology for correction myopia.


Chengdu Aier eye hospital, China.


This study evaluated 79 eyes of 40 patients who underwent Hole ICL implantation with spherical equivalents of -10.17±3.67D. The uncorrected (UDVA) and corrected (CDVA)distance visual acuities, refractive error , intraocular pressure, endothelial cell count,central vault, and adverse events of the surgery were recorded before and up to 3 month after surgery.


At 3 months postoperatively, the mean spherical equivalent decreased to -0.07±0.29D,93.6% of eyes were within ±0.5D and 100% eyes were within ±1.00D of targeted correction. The mean UCVA and CDVA were 20/20 or better in 96.2% and100 % of eyes respectively. The safety and efficacy indices 1.35±0.23 and 1.22±0.28 respectively . No significant rise in intraocular pressure(including pupillary block) or secondary cataract occurred in any case during the period of observation. At 3 months the mean vault was 410.55±169.47um (range190 to 680 um) and the endothelial cell loss was 2.9%.


Implantation of Hole ICL offered good results for all measures of safety,efficacy predictability and stability for the correction of high myopia, even without peripheral iridotomy or iridectomy.

Financial Disclosure:


Back to Poster listing